Locked Nucleic Acids (LNA) and Medical Applications

  • Henrik Ørum
  • Andreas Wolter
  • Lars Kongsbak
Part of the Medical Intelligence Unit book series (MIUN)


Capture Probe Peptide Nucleic Acid Cationic Lipid Lock Nucleic Acid Allele Specific Amplification 
These keywords were added by machine and not by the authors. This process is experimental and the keywords may be updated as the learning algorithm improves.


Unable to display preview. Download preview PDF.

Unable to display preview. Download preview PDF.


  1. 1.
    Choleva Y, Noerholm M, Pedersen S et al. Multiplex SNP genotyping using locked nucleic acid and microfluidics. Jala 2001; (6):92–97.Google Scholar
  2. 2.
    Wengel J, Nielsen P. Oligonucleotide analogues. WO 99/14226.Google Scholar
  3. 3.
    Arzumanov A, Walsh AP, Rajwanshi VK et al. Inhibition of HIV-1 Tat-dependent trans activation by steric block chimeric 2′-0-Methyl/LNA oligoribonucleotides. Biochemistry 2001; 40:14645–14654.PubMedCrossRefGoogle Scholar
  4. 4.
    Oerum H, Jacobsen MH, Koch T et al. Detection of the factor V leiden mutation by direct allele-specific hybridization of PCR amplicons to photo-immobilized locked nucleic acids. Clin Chem 1999; 45(11):1898–1905.Google Scholar
  5. 5.
    Singh SK, Nielsen P, Koshkin A et al. Wengel J. LNA (locked nucleic acids): Synthesis and high-affinity nucleic acid recognition. Chem Commun 1998;455–456.Google Scholar
  6. 6.
    Morita K, Hasegawa C, Kaneko M et al. 2′-0,4-C-ethylene-bridged nucleic acids (ENA): Highly nuclease-resistant and thermodynamically stable oligonucleotides for antisense drug. Bioorg Med Chem Lett 2002; 12;73–76.PubMedCrossRefGoogle Scholar
  7. 7.
    Obika S, Hemamayi R, Masuda T et al. Inhibition of ICAM-I gene expression by antisense 2′,4′-BNA oligonucleotides. Nucl Acid Res (Suppl) 2001; 1:145–146.Google Scholar
  8. 8.
    Obika S, Onoda M, Morita K et al. 3′-Amino-2′,4′-BNA: Novel bridged nucleic acids having an N3′-P5′ phosphoramidate linkage. Chem Commun 2001; 1992–1993.Google Scholar
  9. 9.
    Wahlestedt C, Salmi P, Good L et al. Potent and nontoxic antisense oligonucleotides containing locked nucleic acids. Proc Natl Acad Sci USA 2000; 97(10):5633–5638.PubMedCrossRefGoogle Scholar
  10. 10.
    Soerensen MD, Kværnø L, Bryld T et al. Alpha-L-LNA (alpha-L-ribo-configures locked nucleic Acid): Synthesis and properties. J Am Chem Soc 2002; 124(10):2164–2176.CrossRefGoogle Scholar
  11. 11.
    Bondensgaard K, Petersen M, Singh SK et al. Structural studies of LNA:RNA duplexes by NMR: Conformations and implications for RNase H activity. Chem Eur J 2000; 6(15):2687–2695.CrossRefGoogle Scholar
  12. 12.
    ten Asbroek ALMA, Fluiter K, van Wiji J et al. Locked nucleic acids increase the antisense potency of phosphorothioate oligonucleotides. preparation.Google Scholar
  13. 13.
    Petersen M, Hakansson AE, Wengel J et al. Alpha-L-LNA (alpha-L-ribo configured locked nucleic acid) recognition of RNA. A study by NMR spectroscopy and molecular dynamics simulations. J Am Chem Soc 2001; 123(30):7431–7432.PubMedCrossRefGoogle Scholar
  14. 14.
    Koch T, Jacobsen N, Fensholdt J et al. Photochemical immobilization of anthraquinone conjugated oligonucleotides and PCR amplicons on solid surface. Bioconjugate Chemistry 2000; 11(4):474.PubMedCrossRefGoogle Scholar
  15. 15.
    Bennett CF, Chiang MY, Chan H et al. Cationic lipids enhance cellular uptake and activity of phosphorothioate antisense oligonucleotides. Mol Pharmacol 1992; 41(6): 1023–33.PubMedGoogle Scholar
  16. 16.
    Zelphati O, Szoka Jr FC. Intracellular distribution and mechanism of delivery of oligonucleotides mediated by cationic lipids. Pharm Res 1996; 13(9): 1367–72.PubMedCrossRefGoogle Scholar
  17. 17.
    ten Asbroek ALMA, Fluiter K, van Groenigen M et al. Polymorphisms in the large subunit of human RNA polymerase II as target for allele-specific inhibition. Nucl Acids Res 2000; 28:1133–1138.PubMedCrossRefGoogle Scholar
  18. 18.
    Toth JG, Sarnyai Z, Chan J et al. Behavioral analysis of D2 dopamine receptor functions in the mouse brain by using novel antisense chemistry based on locked nucleic acids (LNA). Society for Neuroscience Abstracts 2001; 27(1): 1431.Google Scholar
  19. 19.
    Obika S, Nanbu D, Hari Y et al. Stability and structural features of the deplexes containing nucleoside analogues with a fixed N-type conformation, 2′-0,4′-C-methyleneribonucleosides. Tetrahed lett 1998; 39:5401–5404.CrossRefGoogle Scholar
  20. 20.
    Stein CA. Antisense that comes naturally. Nature 2001; 19:737.CrossRefGoogle Scholar
  21. 21.
    Ruvkun G. Glimpses of a Tiny RNA World. Science 2001; 294:797–799.PubMedCrossRefGoogle Scholar

Copyright information

© and Kluwer Academic / Plenum Publishers 2006

Authors and Affiliations

  • Henrik Ørum
    • 1
  • Andreas Wolter
    • 2
  • Lars Kongsbak
    • 3
  1. 1.Santaris Pharma A/SHørshomDenmark
  2. 2.Proligo GmbHHamburgGermany
  3. 3.Exiqon A/SVedbækDenmark

Personalised recommendations